Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhEGF in diabetic foot ulcer with uncontrolled diabetes
NCT01629199Phase 3Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Oct 2010
- Primary completion
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of nepidermin in diabetic foot ulcer (DFU), sponsored by Daewoong Pharmaceutical. Started Oct 2010; status: completed.
02
Drugs
nepidermin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT01629199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01629199.